Published 3 years ago

Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

Summary by CBC News

Pfizer publicly released data from its coronavirus vaccine trial appearing to show that it's both safe and effective for children aged five to 11. But that data is now being reviewed by regulators, and parents want to carefully weigh the risks.

0 Articles

All

Left

Center

Right

CBC News

Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

3 years ago·Canada

Read Full Article

Saudi Gazette

Pfizer: COVID-19 vaccine 91% effective in children aged 5-11

The FDA will post its own analysis of Pfizer's safety and efficacy data later on Friday. If the panel votes favorably, and the agency accepts the recommendations, the Centers for Disease Control and Prevention will make the ultimate decision on who should get the shots.

3 years ago·Jeddah, Saudi Arabia

Read Full Article

Brussels Times

Pfizer Covid-19 vaccine 90% effective in 5 to 11-year-olds

The Pfizer-BioNTech vaccine is 90.7% effective in preventing symptomatic forms of the coronavirus in children aged five to 11, Pfizer announced on Friday. The company made the announcement in a document supporting its application for emergency use authorisation (EUA) for that age group in the United States, which was posted on the US Federal Drug […]

3 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left2Leaning Right0Center0Last Updated3 years agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

0 Articles

0 Articles

Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

Pfizer: COVID-19 vaccine 91% effective in children aged 5-11

Pfizer: COVID-19 vaccine 91% effective in children aged 5-11

Pfizer Covid-19 vaccine 90% effective in 5 to 11-year-olds

Pfizer Covid-19 vaccine 90% effective in 5 to 11-year-olds

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics